Conference Call to be Held on
March 30, 2023
CORDOVA, Calif., March 28,
2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc.
(Nasdaq: THMO), a market leader in automated cell processing and
point-of-care, autologous cell-based therapies, today announced
that the Company will release its financial results for the year
ended December 31, 2022 and provide a
corporate strategic update on Thursday,
March 30, 2023, after the close of trading. A conference
call and webcast will follow at 1:30 p.m.
PT/ 4:30 p.m. ET.
To participate in the conference call, please dial
1-844-889-4331 (domestic), 1-412-380-7406 (international)
or 1-866-605-3852 (Canada). To
access a live webcast of the call, please
A webcast replay will be available on ThermoGenesis' website for
three months by visiting the Investor page of the Company's website
About ThermoGenesis Holdings, Inc.
Holdings, Inc. develops, commercializes, and markets a range of
automated technologies for CAR-T and other cell-based therapies.
The Company currently markets a full suite of solutions for
automated clinical biobanking, point-of-care applications, and
automation for immuno-oncology, including its semi-automated,
functionally closed CAR-TXpress™ platform, which streamlines the
manufacturing process for the emerging CAR-T immunotherapy market.
For more information about ThermoGenesis, please visit:
Paula Schwartz, Rx Communications
SOURCE ThermoGenesis Holdings, Inc.